Alzheimer Disease and Dementia
Medicare Coverage of Aducanumab for Alzheimer Disease: The Impact of the Decision
- Propranolol Shows Potential as Pharmacokinetic Treatment for AD
- Medication Has Little Effect on Emotional Blunting in MDD
- Non-Alzheimer Dementia Risk Tied to Physical Activity During Leisure Time
- Naloxone Out-of-Pocket Expenses May Present Barrier for Uninsured
- Telehealth Services Usage for Opioid Use Disorder Increased During Pandemic
- Anxiety, Depression Scores Increased in Meniere Disease, Vertigo
- US Preventive Services Task Force Recommends Depression Screening for All Adults
- Acupuncture May Ease Anxiety in Patients With Parkinson Disease
- Toxoplasmosis Infection Has a Possible Causal Relationship With Bipolar Disorder
- Time and Perspective Affects Disease Trajectory in MDD, Anxiety
- Trial Evaluating Pfizer’s Quadrivalent mRNA Influenza Vaccine Begins
- Veterans’ Health: The Link Between Blast Exposure and Respiratory Symptoms
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
What Is the Impact of Sex Hormones on Susceptibility to Autoimmune Inflammatory Diseases?
The Risk for Long COVID Tied to Vaccine Doses in Health Care Workers
Olfactory Training With Noninvasive Brain Stimulation Improves COVID-19 Anosmia
Retinal Microvascular Biomarkers May Suggest Euthymic Bipolar Disorder
Monkeypox: Clinical Characteristics and Common Complications
